While melanoma cells that express HLA class II molecules typically express measurable levels of Ii and HLA-DM, the detection of GILT within these tumor lines varies, with some tumors expressing little to no GILT enzyme [15,50]. This evidence concerns the gene IFI30 and neoplasm.